Association of the Innate Immunity and Inflammation Pathway with Advanced Prostate Cancer Risk

• Rémi Kazma,

  Affiliation Department of Epidemiology and Biostatistics and Institute for Human Genetics, University of California San Francisco, San Francisco, California, United States of America

  ⨯
• Joel A. Mefford,

  Affiliation Department of Epidemiology and Biostatistics and Institute for Human Genetics, University of California San Francisco, San Francisco, California, United States of America

  ⨯
• Iona Cheng,

  Affiliation Epidemiology Program, University of Hawai’i Cancer Center, University of Hawai’i, Honolulu, Hawai’i, United States of America

  ⨯
• Sarah J. Plummer,

  Affiliation Department of Preventive Medicine, Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, California, United States of America

  ⨯
• Albert M. Levin,

  Affiliation Department of Biostatistics and Research Epidemiology, Henry Ford Health System, Detroit, Michigan, United States of America

  ⨯
• Benjamin A. Rybicki,

  Affiliation Department of Biostatistics and Research Epidemiology, Henry Ford Health System, Detroit, Michigan, United States of America

  ⨯
• Graham Casey,

  Affiliation Department of Preventive Medicine, Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, California, United States of America

  ⨯
• John S. Witte

  * E-mail: wittej@humgen.ucsf.edu

  Affiliation Department of Epidemiology and Biostatistics and Institute for Human Genetics, University of California San Francisco, San Francisco, California, United States of America

  ⨯